Airway Pharmacology and Treatment最新文献

筛选
英文 中文
Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria 根据EUFOREA 2021标准,重度CRSwNP患者对mepolizumab的反应
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3536
C. Hopkins, Joseph K. Han, V. Lund, C. Bachert, Z. Diamant, W. Fokkens, A. Sousa, Steven G. Smith, Shibing Yang, B. Mayer, S. Yancey, R. Chan, Stella E. Lee
{"title":"Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria","authors":"C. Hopkins, Joseph K. Han, V. Lund, C. Bachert, Z. Diamant, W. Fokkens, A. Sousa, Steven G. Smith, Shibing Yang, B. Mayer, S. Yancey, R. Chan, Stella E. Lee","doi":"10.1183/13993003.congress-2021.pa3536","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3536","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76810466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term effect of alpha-1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients α -1抗胰蛋白酶增强治疗对缺乏患者FEV1下降的长期影响
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa1833
I. G. Schouten, M. Kasteleyn, R. Bals, A. Turner, I. Ferrarotti, A. Corsico, Beatriz Lara Gallego, M. Miravitlles, R. Stockley, J. Stolk
{"title":"Long-term effect of alpha-1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients","authors":"I. G. Schouten, M. Kasteleyn, R. Bals, A. Turner, I. Ferrarotti, A. Corsico, Beatriz Lara Gallego, M. Miravitlles, R. Stockley, J. Stolk","doi":"10.1183/13993003.congress-2021.pa1833","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa1833","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87887790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Asthma control and oral corticosteroids in Severe Asthma 重度哮喘患者口服糖皮质激素与哮喘控制的评价
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3529
C. Micheletto, M. Bilò, L. Antonicelli, F. De Michele, A. Musarra, A. Vagni
{"title":"Evaluation of Asthma control and oral corticosteroids in Severe Asthma","authors":"C. Micheletto, M. Bilò, L. Antonicelli, F. De Michele, A. Musarra, A. Vagni","doi":"10.1183/13993003.congress-2021.pa3529","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3529","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"2015 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86890301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled JAK inhibitor GDC-4379 reduces FeNO in patients with mild asthma 吸入JAK抑制剂GDC-4379可降低轻度哮喘患者的FeNO
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.oa1196
Hubert C. Chen, R. Kunder, Yixuan Zou, Hallam M Gugelmann, J. Galanter, Rui Zhu, R. Owen, Tracy Staton, M. Wright, M. Durk, A. Eliahu, M. Wilson, R. Beasley, I. Braithwaite
{"title":"Inhaled JAK inhibitor GDC-4379 reduces FeNO in patients with mild asthma","authors":"Hubert C. Chen, R. Kunder, Yixuan Zou, Hallam M Gugelmann, J. Galanter, Rui Zhu, R. Owen, Tracy Staton, M. Wright, M. Durk, A. Eliahu, M. Wilson, R. Beasley, I. Braithwaite","doi":"10.1183/13993003.congress-2021.oa1196","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.oa1196","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"39 11 Pt 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82830546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals 氟康唑对健康人烯西芬碱药动学的影响
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa2137
T. Rheault, M. Kankam, J. Ayrton, T. Bengtsson, K. Rickard
{"title":"The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals","authors":"T. Rheault, M. Kankam, J. Ayrton, T. Bengtsson, K. Rickard","doi":"10.1183/13993003.congress-2021.pa2137","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa2137","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"123 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91446025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stepped treatment algorithm for chronic respiratory disease using budesonide-formoterol in a rural healthcare setting in Vietnam 在越南农村卫生保健机构使用布地奈德-福莫特罗治疗慢性呼吸道疾病的阶梯式治疗算法
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa875
E. Huang, Greg Fox, N. Pham, T. Nguyen, Van Giap Vu, Phuong Phan Thu, Q. Ngo, V. Nguyen, Guy Marks
{"title":"A stepped treatment algorithm for chronic respiratory disease using budesonide-formoterol in a rural healthcare setting in Vietnam","authors":"E. Huang, Greg Fox, N. Pham, T. Nguyen, Van Giap Vu, Phuong Phan Thu, Q. Ngo, V. Nguyen, Guy Marks","doi":"10.1183/13993003.congress-2021.pa875","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa875","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83404961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab benralizumab治疗的严重嗜酸性哮喘患者体重的现实影响
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3735
F. Menzella, M. Aliani, Elena Altieri, P. Bracciale, S. Centanni, F. De Michele, F. Di Marco, G. Pelaia, M. Romagnoli, Pietro Schino, S. Boarino, G. Vitiello, P. Rogliani
{"title":"Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab","authors":"F. Menzella, M. Aliani, Elena Altieri, P. Bracciale, S. Centanni, F. De Michele, F. Di Marco, G. Pelaia, M. Romagnoli, Pietro Schino, S. Boarino, G. Vitiello, P. Rogliani","doi":"10.1183/13993003.congress-2021.pa3735","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3735","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88525814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study 摘要:在接受benralizumab治疗的严重嗜酸性粒细胞哮喘(SEA)患者中,患者报告结局(PROs)和身体活动(PA)的早期获益:改善哮喘研究的中期分析
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa3538
M. Lommatzsch, S. Korn, T. Plate, Thorsten Grund, H. Watz
{"title":"Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study","authors":"M. Lommatzsch, S. Korn, T. Plate, Thorsten Grund, H. Watz","doi":"10.1183/13993003.congress-2021.pa3538","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa3538","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"112 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89287006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD 结合肺炎球菌疫苗对COPD患者急性发作频率的影响
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa2139
Zeynep Öndeş, Y. Varol, A. Çırak, Burçin Hakoğlu, Serpil Tekgul
{"title":"The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD","authors":"Zeynep Öndeş, Y. Varol, A. Çırak, Burçin Hakoğlu, Serpil Tekgul","doi":"10.1183/13993003.congress-2021.pa2139","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa2139","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80648479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD) 慢性阻塞性肺疾病(COPD)患者启动非固定剂量联合(FDC)联合二丙酸倍氯米松(ef-FDC-BDP)与长效支气管扩张剂(LABD)的肺炎风险
Airway Pharmacology and Treatment Pub Date : 2021-09-05 DOI: 10.1183/13993003.congress-2021.pa560
D. Price, W. Henley, V. Carter, D. Skinner, R. Vella, A. Papi, L. Fabbri, H. Kerstjens, N. Roche, Dave Singh, C. Vogelmeier, E. Sen, J. Cançado, E. Nudo, S. Barile, G. Georges
{"title":"Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)","authors":"D. Price, W. Henley, V. Carter, D. Skinner, R. Vella, A. Papi, L. Fabbri, H. Kerstjens, N. Roche, Dave Singh, C. Vogelmeier, E. Sen, J. Cançado, E. Nudo, S. Barile, G. Georges","doi":"10.1183/13993003.congress-2021.pa560","DOIUrl":"https://doi.org/10.1183/13993003.congress-2021.pa560","url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91172255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信